Search

everythinglearnresearchcommunity

for

Search:↓

Stretching skin increases a certain protein that attracts stem cells, helping skin regeneration.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

New acne treatments show promise as alternatives to traditional therapies.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

GLP-1 agonists may help treat certain skin conditions.

RORA may help regulate hair growth by affecting hair follicle stem cells.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Different fish use the same genes to regrow teeth.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.